Another aspect proving the importance of mechanobiology alterations in AD pathogenesis is the encouraging results from the Phase 1-2a-2b trials of Simufilam (PTI-125), a small molecule targeting an altered form of Filamin A found in the AD brain [225,226]. This evidence concerns the gene FLNA and Alzheimer disease.